Azitra, Inc. Announces Q3 2026 Results and Provides Business Updates

BRANFORD, Conn., Nov. 12, 2026 // -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology and high value cosmetic proteins and peptides, today reported financial resu…